Thiogenesis Therapeutics
$0.3737
1
+$0.00+0%Wednesday 21:00
Statistics
Day High
0.406
Day Low
0.4
52W High
0.5834
52W Low
0.3565
Volume
37,000
Avg. Volume
1,486
Mkt Cap
26.15M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 24Expected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.04
-0.03
-0.02
-0.01
Expected EPS
N/A
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-5.35MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Thiogenesis Therapeutics Corp. engages in the development of novel drug formulations that act as precursors for rare diseases. The company was founded on May 3, 2018 and is headquartered in Toronto, Canada.
Show More
CEO
Patrice Rioux
Country
Canada
ISIN
CA88410L1022
WKN
000A3D51F
Listings
0 Comments
Share your thoughts
FAQs
What is Thiogenesis Therapeutics stock price today?▼
The current price of TTIPF is $0.37 USD — it has increased by +0% in the past 24 hours. Watch Thiogenesis Therapeutics stock price performance more closely on the chart.
What is Thiogenesis Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Thiogenesis Therapeutics stocks are traded under the ticker TTIPF.
Is Thiogenesis Therapeutics stock price growing?▼
TTIPF stock has risen by +0% compared to the previous week, the month change is a +1.8% rise, over the last year Thiogenesis Therapeutics has showed a -35.94% decrease.
What is Thiogenesis Therapeutics market cap?▼
Today Thiogenesis Therapeutics has the market capitalization of 26.15M
When is the next Thiogenesis Therapeutics earnings date?▼
Thiogenesis Therapeutics is going to release the next earnings report on November 24, 2026.
What were Thiogenesis Therapeutics earnings last quarter?▼
TTIPF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Thiogenesis Therapeutics revenue for the last year?▼
Thiogenesis Therapeutics revenue for the last year amounts to 0 USD.
What is Thiogenesis Therapeutics net income for the last year?▼
TTIPF net income for the last year is -5.35M USD.
In which sector is Thiogenesis Therapeutics located?▼
Thiogenesis Therapeutics operates in the Finance & Payments sector.
When did Thiogenesis Therapeutics complete a stock split?▼
Thiogenesis Therapeutics has not had any recent stock splits.
Where is Thiogenesis Therapeutics headquartered?▼
Thiogenesis Therapeutics is headquartered in Toronto, Canada.